St. George Hospital Establishes Cancer Genomics Program
By Ladd Egan
(KUTV) Dixie Regional Medical Center in St. George will be the home to Intermountain Healthcare’s first in-house cancer genomic program, aimed at providing patients with personalized cancer treatments.
Intermountain says the new program will make it one of the first healthcare systems in the country to treat cancer patients using genetic sequencing technologies.
Utah native Dr. Lincoln Nadauld, MD/PhD, has been hired to head the new cancer genomics department. He most recently taught cancer genomics and completed a medical oncology fellowship at Stanford School of Medicine.
“We’re very excited about it,” Nadauld said of the new program at Dixie. “We have a much better chance of giving patients the targeted therapies they could benefit from.”
Nadauld says the techniques he developed at Stanford University help him identify DNA changes in cancer and predict which cancer drugs will be most effective.
“The benefit comes from it being a personalized treatment,” Nadauld said. “So it’s really individualized and tailored to that patient’s specific DNA changes.”
By using targeted cancer treatments, Nadauld says, patients experience fewer side effects. In addition, the genetic sequencing can provide new treatment choices for patients with advanced or hard-to-treat cancers.
“We hope to be able to find more options for those patients, personalized options, for those who otherwise would be running out of hope,” he said.
Just a few years ago, completing genetic sequencing on tumors to guide treatments was too expensive and time consuming for most patients, Nadauld said.
But by integrating the cancer genomics lab within Dixie Regional’s existing cancer center, Nadauld says they will be able to quickly and cost-effectively give doctors valuable treatment guidance.
Because of his extensive training in personalized cancer treatments, combined with his medical and doctoral degrees, Nadauld is among a small group of physicians who specialize in cancer genomic medicine.
“He really comes to us with a new skill set that we’ve not had before,” said Gary Stone, operations officer for Intermountain’s southwest region. “This is cancer care close to home.”
(Copyright 2013 Sinclair Broadcasting Group)
(KUTV) Dixie Regional Medical Center in St. George will be the home to Intermountain Healthcare’s first in-house cancer genomic program, aimed at providing patients with personalized cancer treatments.
Intermountain says the new program will make it one of the first healthcare systems in the country to treat cancer patients using genetic sequencing technologies.
Utah native Dr. Lincoln Nadauld, MD/PhD, has been hired to head the new cancer genomics department. He most recently taught cancer genomics and completed a medical oncology fellowship at Stanford School of Medicine.
“We’re very excited about it,” Nadauld said of the new program at Dixie. “We have a much better chance of giving patients the targeted therapies they could benefit from.”
Nadauld says the techniques he developed at Stanford University help him identify DNA changes in cancer and predict which cancer drugs will be most effective.
“The benefit comes from it being a personalized treatment,” Nadauld said. “So it’s really individualized and tailored to that patient’s specific DNA changes.”
By using targeted cancer treatments, Nadauld says, patients experience fewer side effects. In addition, the genetic sequencing can provide new treatment choices for patients with advanced or hard-to-treat cancers.
“We hope to be able to find more options for those patients, personalized options, for those who otherwise would be running out of hope,” he said.
Just a few years ago, completing genetic sequencing on tumors to guide treatments was too expensive and time consuming for most patients, Nadauld said.
But by integrating the cancer genomics lab within Dixie Regional’s existing cancer center, Nadauld says they will be able to quickly and cost-effectively give doctors valuable treatment guidance.
Because of his extensive training in personalized cancer treatments, combined with his medical and doctoral degrees, Nadauld is among a small group of physicians who specialize in cancer genomic medicine.
“He really comes to us with a new skill set that we’ve not had before,” said Gary Stone, operations officer for Intermountain’s southwest region. “This is cancer care close to home.”
(Copyright 2013 Sinclair Broadcasting Group)

